Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COACH: Olmesartan + Amlodipine in Hypertension
NCT00185133Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan, amlodipine in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started May 2005; status: completed.
02
Drugs
olmesartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00185133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185133.